Grants, awards and donations
Photo: Johan Wingborg/HLFHLF awards major research grant to Charlotte Thålin for COPD inhalation therapy
An estimated 500,000 to 700,000 people in Sweden live with the lung disease COPD. Research is currently being done on developing an inhalation therapy for such patients by examining how antibodies can protect the body from disease-related inflammation and infections. KI researcher Charlotte Thålin has been awarded the Swedish Heart-Lung Foundation’s (HLF) major research grant of SEK 20 million for the project.
Photo: Johannes Frandsén,Johannes FrandsenKI researcher awarded funding to tailor treatment for ovarian cancer
Okan Gültekin, a postdoctoral researcher at Karolinska Institutet, has been awarded an international grant from the Cancer Foundation to develop an AI-based tool for the treatment of advanced ovarian cancer. The project brings together expertise from Sweden, Finland and the UK.
Photo: DepositphotosNew funding for KI researchers working on childhood cancer
Seven researchers affiliated with Karolinska Institutet have been awarded funding in the Swedish Childhood Cancer Fund’s latest call for research positions, with a total allocation of SEK 57 million. The funded projects include initiatives aimed at improving chemotherapy for children with leukemia, as well as studies seeking to better understand relapse in acute lymphoblastic leukemia.
Photo: N/AArnhög Family donates SEK 50 million to research at KI
Businessman and life-science investor Mats Arnhög and his family have pledged SEK 50 million to the research being done at Karolinska Institutet into epilepsy, glioblastoma and Parkinson’s disease. The aim of the donation is to strengthen the early and long-term research that future medical breakthroughs require.
The Conversation
Photo: Photo: I Love Photo.Why we care so much about body odour
Body odour often provokes strong reactions and influences how we perceive others. An article in The Conversation describes what scientific research tells us about body odour, why it has become so socially significant, and what it can signify in certain contexts.
Photo: Getty ImagesWhy has PCOS been given a new name?
After decades of research, PCOS is now being renamed PMOS. The new name reflects a growing understanding that the condition is a complex hormonal and metabolic disorder affecting far more than fertility.
Photo: Getty ImagesThe shot that could stop cancer before it begins
Vaccines like the HPV shot are already proving that cancer can be prevented before it develops, by stopping the infections that trigger it years or even decades later. Evidence from long-term studies shows that getting vaccinated early – before exposure – dramatically reduces cancer risk, highlighting the critical importance of early immunisation.
Photo: Getty ImagesMore articles by KI researchers published in The Conversation
From cold-resistant genes to face masks, Karolinska Institutet researchers contribute to the global public discourse on a range of topics through our collaboration with the international news site The Conversation.
Selected top publications
Staff practices determine the use of coercion against young people
Astrid Moell et al, Lancet Psychiatry, June 2026
From PCOS to PMOS: why the name of a disease matters
Elisabet Stener-Victorin et al, Nature Medicine, May 2026
Chronic bowel disease involves multiple types of inflammation happening at once
Eduardo J. Villablanca et al, Immunity, May 2026
New insights into protein breakdown in cells pave the way for new medicines
Helin Norberg et at, Trends in Pharmacological Sciences, April 2026
More patients receive recommended heart failure treatment
Gianluigi Savarese et al, European Heart Journal, April 2026
More high-impact publications